Mr Richard Eugene Boeckmann, PD | |
411 Falls Blvd S, Wynne, AR 72396-3501 | |
(870) 238-8511 | |
(870) 238-2135 |
Full Name | Mr Richard Eugene Boeckmann |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 411 Falls Blvd S, Wynne, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184625402 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 6609 (Arkansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Richard Eugene Boeckmann, PD 411 Falls Blvd S, Wynne, AR 72396-3501 Ph: (870) 238-8511 | Mr Richard Eugene Boeckmann, PD 411 Falls Blvd S, Wynne, AR 72396-3501 Ph: (870) 238-8511 |
News Archive
Individuals who experience long or short sleep durations are more likely to report poor self-rated health than healthy sleepers, Korean study findings suggest.
The incidence and severity of both traditional and emerging cardiovascular disease (CVD) risk factors as well as the response to treatment may differ between genders. In this narrative review, several emerging CVD risk factors (i.e. inflammatory and haemostatic markers, endothelial dysfunction, homocysteine, lipid disorders, microalbuminuria/proteinuria, coronary artery calcium score, arterial stiffness, periodontitis, inflammatory bowel syndrome, obstructive sleep apnea, impaired glucose metabolism, metabolic syndrome and non-alcoholic fatty liver disease) are discussed in the context of gender differences.
A recent study found no significant difference in the outcome for patients who received carotid artery stenting (CAS) at more than 30 days post-transient ischemic attack (TIA) or stroke versus those who received CAS at 30 days or less post-event.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has entered into a research and exclusive license agreement with Teva Pharmaceutical Industries Ltd. to develop and commercialize XMT-1107, a novel fumagillin analog, for the treatment of all indications, including cancer.
› Verified 8 days ago
Dr. Lauren Rebecca Roach, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 804 Falls Blvd S, Wynne, AR 72396 Phone: 870-238-7085 Fax: 870-238-8937 | |
Allisyn Stroupe, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Highway 64 E, Wynne, AR 72396 Phone: 870-238-7146 | |
Mrs. Stacy E Cooper, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 411 Falls Blvd S, Wynne, AR 72396 Phone: 870-238-8511 | |
Kristina R Eppes, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 718 Falls Blvd S, Wynne, AR 72396 Phone: 870-238-8531 Fax: 870-238-5982 | |
Kara Hardin Smith, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Highway 64 E, Wynne, AR 72396 Phone: 870-238-8129 | |
Sara Massey, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 804 Falls Blvd S, Wynne, AR 72396 Phone: 870-238-7085 Fax: 870-238-8937 |